| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 18 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 2 | TACROLIMUS OINTMENT 0.1% | 17 |
| 3 | MYCOPHENOLATE MOFETIL | 14 |
| 4 | METHYLPREDNISOLONE | 13 |
| 5 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 11 |
| 6 | VORICONAZOLE | 11 |
| 7 | VORICONAZOLE INJECTION | 11 |
| 8 | VANCOMYCIN | 10 |
| 9 | AMPHOTERICIN B | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRAHYDROZOLINE HYDROCHLORIDE | 1 | 0.0034 |
| 1 | BARIUM SULFATE | 1 | 0.0023 |
| 2 | SUGAMMADEX SODIUM | 1 | 0.0008 |
| 3 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 4 | AMPHOTERICIN B | 9 | 0.0007 |
| 5 | ELBASVIR AND GRAZOPREVIR | 2 | 0.0005 |
| 6 | VORICONAZOLE | 11 | 0.0004 |
| 7 | ZINC SULFATE INJECTION, | 1 | 0.0003 |
| 8 | LETERMOVIR | 1 | 0.0003 |
| 9 | GANCICLOVIR SODIUM | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 9 | 0.0007 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 4 | Polyene Antifungal [EPC] | 9 | 0.0002 |
| 5 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 10 | 0.0002 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 8 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 11 | 0.0001 |